XML 110 R80.htm IDEA: XBRL DOCUMENT v3.22.4
Business Combinations - Summary of Unaudited Pro Forma Financial Information (Details) - Inform Diagnostics - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]    
Revenue $ 659,386 $ 1,140,184
Net income attributable to Fulgent $ 140,288 $ 493,313
Basic earnings per common share attributable to Fulgent $ 4.66 $ 16.77
Diluted earnings per common share attributable to Fulgent $ 4.53 $ 15.93